Previous Article | Next Article 
Journal of Virology, October 2000, p. 9115-9124, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The LMP2A ITAM Is Essential for Providing B Cells
with Development and Survival Signals In Vivo
Mark
Merchant,
Robert G.
Caldwell, and
Richard
Longnecker*
Department of Microbiology-Immunology,
Northwestern University Medical School, Chicago, Illinois 60611
Received 23 March 2000/Accepted 5 July 2000
In Epstein-Barr virus-transformed B cells, known as lymphoblastoid
cell lines (LCLs), LMP2A binds the tyrosine kinases Syk and Lyn,
blocking B-cell receptor (BCR) signaling and viral lytic replication.
SH2 domains in Syk mediate binding to a phosphorylated immunoreceptor
tyrosine-based activation motif (ITAM) in LMP2A. Mutation of the LMP2A
ITAM in LCLs eliminates Syk binding and allows for full BCR signaling,
thereby delineating the significance of the LMP2A-Syk interaction. In
transgenic mice, LMP2A causes a developmental alteration characterized
by a block in surface immunoglobulin rearrangement resulting in
BCR-negative B cells. Normally B cells lacking cognate BCR are rapidly
apoptosed; however, LMP2A transgenic B cells develop and survive
without a BCR. When bred into the recombinase activating gene 1 null
(RAG
/
) background, all LMP2A transgenic lines produce
BCR-negative B cells that develop and survive in the periphery. These
data indicate that LMP2A imparts developmental and survival signals to
B cells in vivo. In this study, LMP2A ITAM mutant transgenic mice were
generated to investigate whether the LMP2A ITAM is essential for the
survival phenotype in vivo. LMP2A ITAM mutant B cells develop normally,
although transgene expression is comparable to that in previously
described nonmutated LMP2A transgenic B cells. Additionally, LMP2A ITAM
mutant mice are unable to promote B-cell development or survival when
bred into the RAG
/
background or when grown in
methylcellulose containing interleukin-7. These data demonstrate that
the LMP2A ITAM is required for LMP2A-mediated developmental and
survival signals in vivo.
*
Corresponding author. Mailing address: Department of
Microbiology-Immunology, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611. Phone: (312) 503-0467. Fax: (312)
503-1339. E-mail: r-longnecker{at}nwu.edu.
Journal of Virology, October 2000, p. 9115-9124, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Anderson, L. J., Longnecker, R.
(2009). Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood
113: 108-116
[Abstract]
[Full Text]
-
Rovedo, M., Longnecker, R.
(2008). Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase Lyn. J. Virol.
82: 8520-8528
[Abstract]
[Full Text]
-
Guasparri, I., Bubman, D., Cesarman, E.
(2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood
111: 3813-3820
[Abstract]
[Full Text]
-
Rechsteiner, M. P., Berger, C., Weber, M., Sigrist, J. A., Nadal, D., Bernasconi, M.
(2007). Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J. Gen. Virol.
88: 1454-1459
[Abstract]
[Full Text]
-
Wang, S., Wang, S., Maeng, H., Young, D. P., Prakash, O., Fayad, L. E., Younes, A., Samaniego, F.
(2007). K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood
109: 2174-2182
[Abstract]
[Full Text]
-
Ross, S. R., Schmidt, J. W., Katz, E., Cappelli, L., Hultine, S., Gimotty, P., Monroe, J. G.
(2006). An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.. J. Virol.
80: 9000-9008
[Abstract]
[Full Text]
-
Brinkmann, M. M., Schulz, T. F.
(2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol.
87: 1047-1074
[Abstract]
[Full Text]
-
Morrison, J. A., Raab-Traub, N.
(2005). Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling. J. Virol.
79: 2375-2382
[Abstract]
[Full Text]
-
Katzman, R. B., Longnecker, R.
(2004). LMP2A Does Not Require Palmitoylation To Localize to Buoyant Complexes or for Function. J. Virol.
78: 10878-10887
[Abstract]
[Full Text]
-
Sutkowski, N., Chen, G., Calderon, G., Huber, B. T.
(2004). Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen. J. Virol.
78: 7852-7860
[Abstract]
[Full Text]
-
Ikeda, A., Merchant, M., Lev, L., Longnecker, R., Ikeda, M.
(2004). Latent Membrane Protein 2A, a Viral B Cell Receptor Homologue, Induces CD5+ B-1 Cell Development. J. Immunol.
172: 5329-5337
[Abstract]
[Full Text]
-
Pike, K. A., Iacampo, S., Friedmann, J. E., Ratcliffe, M. J. H.
(2004). The Cytoplasmic Domain of Ig{alpha} Is Necessary and Sufficient to Support Efficient Early B Cell Development. J. Immunol.
172: 2210-2218
[Abstract]
[Full Text]
-
Portis, T., Dyck, P., Longnecker, R.
(2003). Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood
102: 4166-4178
[Abstract]
[Full Text]
-
Geimonen, E., Fernandez, I., Gavrilovskaya, I. N., Mackow, E. R.
(2003). Tyrosine Residues Direct the Ubiquitination and Degradation of the NY-1 Hantavirus G1 Cytoplasmic Tail. J. Virol.
77: 10760-10868
[Abstract]
[Full Text]
-
Brinkmann, M. M., Glenn, M., Rainbow, L., Kieser, A., Henke-Gendo, C., Schulz, T. F.
(2003). Activation of Mitogen-Activated Protein Kinase and NF-{kappa}B Pathways by a Kaposi's Sarcoma-Associated Herpesvirus K15 Membrane Protein. J. Virol.
77: 9346-9358
[Abstract]
[Full Text]
-
Swanson-Mungerson, M., Ikeda, M., Lev, L., Longnecker, R., Portis, T.
(2003). Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases. J Antimicrob Chemother
52: 152-154
[Full Text]
-
Ikeda, A., Caldwell, R. G., Longnecker, R., Ikeda, M.
(2003). Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling. J. Virol.
77: 5529-5534
[Abstract]
[Full Text]
-
Geimonen, E., LaMonica, R., Springer, K., Farooqui, Y., Gavrilovskaya, I. N., Mackow, E. R.
(2002). Hantavirus Pulmonary Syndrome-Associated Hantaviruses Contain Conserved and Functional ITAM Signaling Elements. J. Virol.
77: 1638-1643
[Abstract]
[Full Text]
-
Portis, T., Longnecker, R.
(2002). Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development. J. Virol.
77: 105-114
[Abstract]
[Full Text]
-
Dehghani, H., Brown, C. R., Plishka, R., Buckler-White, A., Hirsch, V. M.
(2002). The ITAM in Nef Influences Acute Pathogenesis of AIDS-Inducing Simian Immunodeficiency Viruses SIVsm and SIVagm without Altering Kinetics or Extent of Viremia. J. Virol.
76: 4379-4389
[Abstract]
[Full Text]
-
Engels, N., Merchant, M., Pappu, R., Chan, A. C., Longnecker, R., Wienands, J.
(2001). Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Employs the SLP-65 Signaling Module. JEM
194: 255-264
[Abstract]
[Full Text]
-
Higuchi, M., Izumi, K. M., Kieff, E.
(2001). Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA
98: 4675-4680
[Abstract]
[Full Text]